GlassScriptPhysician profile
Patrick Allen Deheer
NPI 1639172034
$492,703.44
in general payments reported to CMS, 2019-2025
32 companies · $48K in 2025
The $48K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $18K · 2021: $44K · 2022: $136K · 2023: $184K · 2024: $29K · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $86K · Gift: $83K · Travel and Lodging: $41K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Food and Beverage: $5,274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $85,748.75 |
| Gift | $83,085.00 |
| Travel and Lodging | $40,652.19 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,256.23 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,455.00 |
| Food and Beverage | $5,274.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $242,884.15 | 2019-2024 | Portfolio, Bun-Yo-Matic, Mtp |
| Iq Med LLC | $111,501.58 | 2022-2023 | |
| Medline Industries LP | $57,481.86 | 2022-2025 | Medline, Medline Industries, INC., Pending |
| Vertex Pharmaceuticals Incorporated | $26,439.61 | 2025 | |
| Nevro Corp. | $21,694.47 | 2022-2024 | Senza, Omnia |
| Heron Therapeutics, INC. | $14,555.96 | 2021-2024 | Zynrelef |
| Globus Medical, INC. | $6,297.19 | 2025 | Senza |
| Endo Pharmaceuticals INC. | $3,115.38 | 2020 | |
| Arthrosurface Incorporated | $2,733.16 | 2019 | |
| Wishbone Medical INC. | $1,833.00 | 2019 | |
| Medical Device Business Services, INC. | $1,170.00 | 2022 | |
| Nvision Biomedical Technologies, INC. | $638.35 | 2021-2022 | |
| Organogenesis INC. | $442.71 | 2019-2021 | |
| Flower Orthopedics Coporation | $300.00 | 2019 | |
| Depuy Synthes Sales INC. | $270.02 | 2020-2025 | Motoband, Hammerlock, Minibunion |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $256.54 | 2019-2023 | Augment Injectable, Viaflow, Inbone |
| Kerecis Limited | $156.27 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $147.69 | 2019-2024 | Grafix Pl, Grafix |
| Grt US Holding, INC. | $145.98 | 2022 | |
| Medtronic, INC. | $103.25 | 2022-2023 | Intellis Adaptivestim |
| Treace Medical Concepts, INC. | $94.27 | 2022-2025 | |
| Paratek Pharmaceuticals, INC. | $69.91 | 2023-2025 | Nuzyra |
| Orthofix Medical, INC. | $69.79 | 2022-2025 | Physio-Stim |
| Wright Medical Technology, INC. | $67.03 | 2019 | |
| Zimmer Biomet Holdings, INC. | $46.17 | 2020-2021 | |
| Inari Medical, INC. | $39.66 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanara Medtech INC. | $34.00 | 2021 | |
| Tactile Systems Technology INC | $30.58 | 2019-2025 | Flexitouch Plus, Nimbl |
| Djo, LLC | $28.75 | 2022 | |
| Dynasplint Systems INC. | $23.59 | 2025 | Dynasplint |
| Avita Medical Americas, LLC | $20.26 | 2024 | |
| Baudax Bio INC. | $12.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$845,804.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Deheer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.